Description
Производные триазола - это самая большая группа фунгицидов, относится к классу азолов.
ATX code
J02AC.
Is used
Производные триазолов применяются как биологически активные вещества различного действия, обладают противобактериальной, нейролептической, гипотензивной и спазмолитической активностью, стимулируют сердечную деятельность. Используются как лиганды в металлорганических комплексах, как оптические отбеливатели, полупродукты для получения пластификаторов, ингибиторы коррозии, гербициды, катализаторы.
Used in the treatment of
- Y43.1 Adverse effects in therapeutic use, antineoplastic antimetabolites
- Y43.2 Adverse effects in therapeutic use, antineoplastic natural products
- Y43.3 Adverse effects in therapeutic use, other antineoplastic drugs
- Y84.2 Abnormal reaction/later complication, radiological procedure and radiotherapy
- Y88.0 Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use
- Z29.8 Other specified prophylactic measures
- Z51.0 Radiotherapy session
- Z51.1 Chemotherapy session for neoplasm
- Z94 Transplanted organ and tissue status
- Z94.9 Transplanted organ and tissue status, unspecified
- Z97.2 Presence of dental prosthetic device (complete)(partial)
- C80 Malignant neoplasm without specification of site
- C96.9 Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
- D84.9 Immunodeficiency, unspecified
- G02.1 Meningitis in mycoses
- K65.9 Peritonitis, unspecified
- B20.3 HIV disease resulting in other viral infections
- B20.4 HIV disease resulting in candidiasis
- B20.5 HIV disease resulting in other mycoses
- N48.6 Induratio penis plastica
- N51.2 Balanitis in diseases classified elsewhere
- B35-B49 Mycoses
- B35 Dermatophytosis
- B35.1 Tinea unguium
- B35.2 Tinea manuum
- B35.3 Tinea pedis
- B35.4 Tinea corporis
- B35.6 Tinea cruris
- B35.8 Other dermatophytoses
- B36.0 Pityriasis versicolor
- B36.9 Superficial mycosis, unspecified
- B37 Candidiasis
- B37.0 Candidal stomatitis
- B37.1 Pulmonary candidiasis
- B37.2 Candidiasis of skin and nail
- B37.3 Candidiasis of vulva and vagina (N77.1*)
- B37.4 Candidiasis of other urogenital sites
- B37.5 Candidal meningitis (G02.1*)
- B37.6 Candidal endocarditis (I39.8*)
- B37.7 Candidal sepsis
- B37.8 Candidiasis of other sites
- B37.9 Candidiasis, unspecified
- B38 Coccidioidomycosis
- B39 Histoplasmosis
- B41 Paracoccidioidomycosis
- B42 Sporotrichosis
- B45 Cryptococcosis
- B45.0 Pulmonary cryptococcosis
- B45.1 Cerebral cryptococcosis
- B45.2 Cutaneous cryptococcosis
- B45.8 Other forms of cryptococcosis
- B45.9 Cryptococcosis, unspecified
- B48.7 Opportunistic mycoses
- B48.8 Other specified mycoses
- B49 Unspecified mycosis
- R82.9 Other and unspecified abnormal findings in urine
- T66 Unspecified effects of radiation
- A41.9 Sepsis, unspecified
- B44 Aspergillosis
- B44.0 Invasive pulmonary aspergillosis
- B44.7 Disseminated aspergillosis
- Z94.8 Other transplanted organ and tissue status
- C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
- H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere
- B24 Unspecified human immunodeficiency virus [HIV] disease
- B40 Blastomycosis
- B48 Other mycoses, not elsewhere classified